Author: Bill Snyder
Mar. 15, 2018—K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22.
Mar. 6, 2018—Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).
Mar. 1, 2018—Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery.
Feb. 15, 2018—Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.
Feb. 15, 2018—Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22.
Feb. 8, 2018—Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.
Feb. 8, 2018—Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD).
Feb. 8, 2018—Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people.